3.6. SCF
At the start of the intervention, no difference in concentration of SCF between the active treatment and placebo groups could be demonstrated (active: 527 pg/mL vs. placebo: 577 pg/mL; To validate the results, we applied an ANCOVA, including several variables known to influence cardiovascular prognosis and associated with SCF (